参考文献:1. Abman SH (2002) Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 87:F15鈥揊18 CrossRef 2. Brownlee JR, Beekman RH, Rosenthal A (1988) Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension. Pediatr Res 24:186鈥?90 CrossRef 3. Clark PL, Ekekezie II, Kaftan HA, Castor CA, Truog WE (2002) Safety and efficacy of nitric oxide in chronic lung disease. Arch Dis Child Fetal Neonatal Ed 86:F41鈥揊45 CrossRef 4. Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163:1723鈥?729 5. Subhedar NV (2004) Recent advances in diagnosis and management of pulmonary hypertension in chronic lung disease. Acta Paediatr Suppl 93(444):29鈥?2 6. The Neonatal Inhaled Nitric Oxide Study Group (1997) Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 336:597鈥?04 CrossRef
作者单位:Enrico Rosati (1) Gianfranco Butera (2) Eduardo Bossone (3) Claudio De Felice (4) Giuseppe Latini (1) (5)
1. Division of Neonatology, Perrino Hospital, S.S. 7 per Mesagne, 72100, Brindisi, Italy 2. Pediatric Cardiology, IRCCS Policlinico San Donato, Via Morandi 30, 20097, San Donato Milanese, Italy 3. Institute of Respiratory Disease, University of Milan, IRCCS Ospedale Maggiore, Milan, Italy 4. Neonatal Intensive Care Unit, Azienda Ospedaliera Universitaria Senese, Siena, Italy 5. Clinical Physiology Institute, National Research Council of Italy (IFC-CNR), Lecce, Italy